IAS Gyan

Daily News Analysis

“National Biopharma Mission”

25th September, 2020 Science and Technology

Context: NBM is supporting small and medium enterprises for biopharmaceutical product development, enhancing industry academia interlinkages and providing opportunities to translate knowledge into products/technologies for vaccines, biotherapeutics, devices and diagnostics.
About:

The National Biopharma Mission was approved with an aim to transform the health standards of the country through affordable product development and bring 5-7 biopharmaceutical products closer to market.

Objectives and goals of the Mission are:

  1. a) Specific Product development under vaccines, biosimilars and medical devices
  2. b) Building shared infrastructure for product testing, characterization and manufacturing
  3. c) Promoting scientific research through establishment of translational research consortia and development of novel biopharmaceuticals and devices
  4. d) skill development though trainings 
  5. e)  creating and enhancing technology transfer and intellectual property management.
  • The Mission is supporting small and medium enterprises for biopharmaceutical product development, enhancing industry academia interlinkages and providing opportunities to translate knowledge into products/technologies for vaccines, biotherapeutics, devices and diagnostics.
  • The indigenous manufacturing is promoted through the supported shared facilities for process optimization, clinical grade manufacturing of Biologics, Analytical testing labs, cell line repository, prototyping facilities, large animal testing facilities and medTech zone for manufacturing devices and diagnostics at large scale.
  • These high capital facilities provide easy access to equipment and infrastructure thus encouraging indigenous manufacturing.
  • Technology transfer offices have been established to support technology transfer and support entrepreneurship.
  • Financial and mentorship support has been provided to industry and academia for indigenous product development.
  • This includes projects on development of components of upstream and downstream biologics manufacturing, such as engineered cell lines, media, resins and bioreactors which are currently in-licensed, requiring huge capital.
  • To boost innovation, Mission is also supporting development of novel biologics, novel vaccines and medical devices like MRI, ventilators, diagnostic probes and Medical grade camera.

https://pib.gov.in/PressReleasePage.aspx?PRID=1658689